News | August 10, 2020
For the fifth consecutive year, Galderma donated backpacks filled with school supplies to Northwest Independent School District (NISD) students. This year, Galderma donated 1,200 backpacks for students in grades Kindergarten through 12,...
News | August 7, 2020
SoftWave Tissue Regeneration Technologies plans to start a 60-patient study to evaluate the safety and efficacy of the DermaGold device for the temporary improvement in the appearance of cellulite. The company has a...
News | August 7, 2020
Arcutis Biotherapeutics, Inc. shared positive results from a Phase 1/2a trial of its investigational drug topical roflumilast cream for the treatment of chronic plaque psoriasis that were published in the August issue of the Journal of...
News | August 6, 2020
Two new studies reinforce the efficacy and safety of Dupixent for the treatment of atopic dermatitis in children and adults. In the Phase 3 LIBERTY AD pediatric trial data, nearly three times as many children achieved clear or...
News | August 5, 2020
Leaders from academic dermatology and education are joining together to create a comprehensive dermatology atlas to address what they say has become a well-documented gap in dermatology education. The atlas will display side-by-side images...
Acquisitions and Mergers
Business of Medicine
Earnings and Financials
Phase 3/4 Trials
Product Launches and Updates
Research and Publications
Skin of Color
Galderma Gives Back: Company Donates 1,200 Backpacks Filled with School Supplies to Northwest ISD Students
Early Study Demonstrates Roflumilast cream Safe and Effective for Chronic Plaque Psoriasis
New Data Supports the Safety and Efficacy of Dupixent in Adults and Children with AD
New Dermatology Atlas to Highlight and Compare Features of Common Dermatologic Conditions in Different Skin Types
Third Pivotal Phase 3 Study Shows Rinvoq Plus Topical Corticosteroids Improves Skin and Itch Symptoms in Atopic Dermatitis
New York’s Mount Sinai Health System Names New Chair of Dermatology and New Dean For Clinical Therapeutics
Industry Responds to COVID-19: Cyrex Labs Offers Multiple Autoimmune Reactivity Screen
Genentech’s Tecentriq plus Cotellic and Zelboraf Approved for Advanced Melanoma
DermWireTV: Climate Change and Skin, Wynzora, Tremfya, Rinvoq Updates
And the Winner Is...Dr. Junko Takeshita of University of Pennsylvania Wins 2020 Childhood Eczema Challenge Grant